ENFN - Enfusion, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
150,349
150,349
111,700
79,565
59,027
Cost of Revenue
47,100
47,100
31,845
21,358
16,961
Gross Profit
103,249
103,249
79,855
58,207
42,066
Operating Expenses
Research Development
17,163
17,163
153,400
6,318
4,146
Selling General and Administrative
98,050
98,050
202,339
45,815
24,051
Total Operating Expenses
115,213
115,213
355,739
52,133
28,197
Operating Income or Loss
-11,964
-11,964
-275,884
6,074
13,869
Interest Expense
-
-
4,594
1,662
724
Total Other Income/Expenses Net
-638
-638
-1,185
82
-3
Income Before Tax
-12,189
-12,189
-281,663
4,494
13,142
Income Tax Expense
1,074
1,074
579
433
486
Income from Continuing Operations
-13,263
-13,263
-282,242
4,061
12,656
Net Income
-7,654
-7,654
-282,242
4,061
12,656
Net Income available to common shareholders
-8,608
-8,608
-282,242
4,061
12,656
Basic EPS
-
-
-2.26
0.06
0.20
Diluted EPS
-
-
-2.26
0.06
0.20
Basic Average Shares
-
-
83,045
64,067
64,067
Diluted Average Shares
-
-
83,045
64,067
64,067
EBITDA
-
-5,620
-273,094
8,447
15,023